# Disc Medicine

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/disc-medicine

- Industry: Biotechnology
- Headquarters: Watertown, US
- Website: www.discmedicine.com/
- Total disclosed funding: $140M
- Latest round: Series B (Sep 2, 2021)
- Investors on record: 11

## About

Based in Massachusetts, US, and founded in 2017 by Brian MacDonald, Ph.D., Disc Medicine, Inc. operates as a biopharmaceutical company that provides advanced therapies for hematologic diseases to transform scientific discoveries into life-saving treatments for patients. In June 2024, Disc Medicine, Inc. raised approximately USD 178 million in PIPE funding led by Frazier Life Sciences Management, Lp, and Logos Capital, with participation from Access Industries, Atlas Venture, Janus Henderson Investors, OrbiMed Advisors, Wellington Management, Adage Capital Management, Paradigm Biocapital Advisors, and TCG Crossover Management. As part of the transaction, the company agreed to sell 4.94 million shares of common stock at USD 36 per share. As of 2024, the company is led by its CEO, John Quisel, Ph.D. The firm trades on Nasdaq under the ticker symbol IRON.

The company provides a wide range of therapies for rare genetic disorders, blood cancers, and chronic diseases affecting millions. Additionally, the firm also provides services such as clinical trials and disease management solutions.

## Funding rounds

- Series B, Sep 2, 2021, $90M — Atlas Venture, OrbiMed Advisors, Alexandria Venture Investments, 5AM Ventures, Access Industries, Nantahala Capital Management, Novo Holdings, Rock Springs Capital, Arix Bioscience, Janus Henderson Investors, Willett Advisors LLC
- Series A, Oct 29, 2019, $50M — Atlas Venture, Access Industries, Novo Holdings

## Investors

- Atlas Venture (https://capitalatlas.ai/funds/atlas-venture) — Series A, Series B
- Access Industries (https://capitalatlas.ai/funds/access-industries) — Series A, Series B
- Novo Holdings — Series A, Series B
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series B
- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series B
- 5AM Ventures (https://capitalatlas.ai/funds/5am-ventures) — Series B
- Nantahala Capital Management — Series B
- Rock Springs Capital — Series B
- Arix Bioscience (https://capitalatlas.ai/funds/arix-bioscience) — Series B
- Janus Henderson Investors — Series B
- Willett Advisors LLC — Series B